Intellectual Property India Publishes Patent Application for 'Bispecific Agonistic Antibodies To Activin A Receptor Like Type 1 (ALK1)' Filed by Diagonal Therapeutics Inc.

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517096057 A) filed by Diagonal Therapeutics Inc., Cambridge, U.S.A., on Oct. 6, for 'bispecific agonistic antibodies to activin a receptor like type 1 (alk1).'

Inventor(s) include Lugovskoy, Alexey Alexandrovich; Hus, Jean-Christophe; and Geddie, Melissa.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are bispecific agonistic antibodies that bind to ALK1, BMPR2, ActRIIA, and/or ActRIIB, and methods of using the same."

The patent application was internationally filed on Apr. 05, 2024, under International application No.PCT/US2024/023386.

Disclaimer: Curated by HT Syndication.